Related Experiment Video
Updated: Jun 4, 2026

Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells
Published on: May 20, 2020
Basic principles for the study of metastasis using animal models
1CRC Centre for Cancer Therapeutics, McElwain Laboratories, Institute of Cancer Research, Surrey, UK.
Abstract:
Metastasis is the most devastating aspect of cancer, and the major reason for treatment failure. It is perhaps surprising, therefore, that it is only relatively recently that a wide variety of clinically relevant metastasis models have become generally available. For more than 20 years, the mainstays of cancer research were a handful of transplanted rodent tumors. A few of these (most notably B16F10 and Lewis lung carcinoma) were used as metastasis models, generally by injecting the cells intravenously to give lung colonies. The cancer research community and pharmaceutical industry could be criticized for coming up with few if any new drugs effective against solid tumor metastases. Yet is this surprising when for many years the "NCI screen" consisted of mouse ascites tumors? These are localized, "liquid" tumors, where drug access is direct and blood supply irrelevant, a poor model for solid deposits in a multiplicity of body compartments with varying vascular architecture and function. Such assays are more likely to produce drugs effective against leukemias (1).
Insights
Clinically relevant metastasis models are now available, improving cancer research. Older models like mouse ascites tumors poorly mimic solid tumor spread, hindering drug development for metastasis.
Area of Science:
- Oncology
- Cancer Metastasis Research
Background:
- Metastasis is a primary driver of cancer treatment failure.
- Historically, cancer research relied on limited rodent tumor models.
- The development of clinically relevant metastasis models has been a recent advancement.
Purpose of the Study:
- To highlight the limitations of traditional cancer models in metastasis research.
- To emphasize the need for improved models that accurately reflect solid tumor metastasis.
- To explain why past drug development efforts have been ineffective against solid tumors.
Main Methods:
- Review of historical cancer research models, including transplanted rodent tumors (e.g., B16F10, Lewis lung carcinoma).
- Critique of the National Cancer Institute (NCI) anticancer drug screening assays.
- Comparison of mouse ascites tumors with solid tumor metastasis in vivo.
Main Results:
- Traditional models, like intravenous injection of B16F10 cells, primarily yielded lung colonies.
- Mouse ascites tumors, used in the NCI screen, are poor models for solid tumors.
- The limitations of ascites models explain the lack of effective drugs for solid tumor metastases.
Conclusions:
- The availability of diverse, clinically relevant metastasis models is crucial for advancing cancer treatment.
- Past reliance on inadequate models like mouse ascites tumors has hampered the development of anti-metastasis therapies.
- Future drug discovery must utilize models that accurately represent the complexity of solid tumor metastasis.
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

